CCMW
COLL icon

Cypress Capital Management (Wyoming)’s Collegium Pharmaceutical COLL Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Sell
6,978
-102
-1% -$3.48K 0.21% 50
2026
Q1 		$234K Buy
+7,080
New +$300K 0.22% 48

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s COLL Position: Q2 2026 in Review

Cypress Capital Management (Wyoming) reduced its Collegium Pharmaceutical (COLL) stake by 1.4% in Q2 2026, selling an estimated $3.48K and leaving 6,978 shares worth $253K. The position accounts for 0.21% of the portfolio, ranked #50.

Cypress Capital Management (Wyoming) first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Cypress Capital Management (Wyoming) held 6,978 shares of Collegium Pharmaceutical worth $253K as of Q2 2026.
  • Cypress Capital Management (Wyoming) sold 102 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.48K.
  • Collegium Pharmaceutical made up 0.21% of Cypress Capital Management (Wyoming)'s portfolio in Q2 2026, its #50 holding.
  • Cypress Capital Management (Wyoming) first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.